L. Perrigo Company recalls allergy relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)15-count cartons (NDC 11673-617-22), b)30-cou…

Recall date

February 9, 2023

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0910-2023

FDA classification

Class II

Brand / firm

L. Perrigo Company

Sold / distributed

Nationwide within the USA

Why it was recalled

Failed Impurities/Degradation Specifications

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

allergy relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)15-count cartons (NDC 11673-617-22), b)30-count cartons (NDC 11673-617-39), c)70-count cartons (NDC 11673-617-01), and d)150-count cartons (11673-617-47), Distributed by: Target Corporation, Minneapolis, MN 55403.